Catalyst Wire Dossier Catalyst Wire Dossier

Envafolimab

envafolimab · 3D Medicines (Sichuan) Co., Ltd.
Drug timelines are a Plus or Pro feature.

62 regulatory and trial events tracked for Envafolimab, covering 2021-09-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma [Phase 2]

See pricing